Sign Up to Review Your Medicare Now

https://quotes.medigaplife.com/find-plans/

Walmart Announces Low Cost Insulin

Walmart announced June 29th it is launching its first-ever private label insulin analog, which will be made available exclusively at its stores.

The retail giant worked directly with manufacturer Novo Nordisk on ReliOn Novolog, allowing it to offer the product in both vials and FlexPens at a far lower price.

The vials will retail for $72.88 and the FlexPens for $85.88, which will save consumers between 58% and 75% off of the cash price for other insulin products, Walmart said in an announcement. That equates to savings of up to $101 per branded vial and $251 per package of branded FlexPens.

The insulin announcements comes directly after the announcement that Walmart is going all-in on telehealth, opening a new front to compete with Amazon.

The acquisition will enable Walmart to expand its Walmart Health service across the country.

“Telehealth offers a great opportunity to expand access and reach consumers where they are and complements our brick-and-mortar Walmart Health locations. Today people expect omnichannel access to care, and adding telehealth to our Walmart Health care strategies allows us to provide in-person and digital care across our multiple assets and solutions,” said Cheryl Pegus, M.D., executive vice president, Health & Wellness in a statement.

“Our Health & Wellness mission is to focus on the consumer’s seamless experience and improved health. We are excited to welcome MeMD employees to the Walmart family, and we are looking forward to together, accelerating health care access across the country,” Pegus said.

The retail giant announced Thursday that its healthcare division, Walmart Health, plans to acquire multi-specialty telehealth provider MeMD.